Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus

Table 3

Clinical outcomes of the study participants.

Outcome	PPI ()	Control ()	value
Baseline HbA1c			<0.001
Follow up HbA1c			<0.001
Change in HbA1c			0.01
CKD	35 (1.4%)	45 (0.6%)	<0.001
Cardiac events	31 (1.3%)	47 (0.7%)	0.004
Dementia	12 (0.5%)	23 (0.3%)	0.223
Mortality	151 (6.2%)	339 (4.8%)	0.005